stockportfolio.pro
IQV vs ZTS: Which Stock Is the Better Buy?
IQVIA Holdings Inc. and Zoetis Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
AI verdict — IQV vs ZTS, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| IQVIA Holdings Inc. (IQV) | Zoetis Inc. (ZTS) | |
|---|---|---|
| Market cap | $34.4B | $32.1B |
| Revenue (latest FY) | $16.31B | $9.47B |
| Net income (latest FY) | $1.36B | $2.67B |
| Revenue growth (5y CAGR) | 7.5% | 7.2% |
| Net margin | 8.3% | 28.2% |
| Return on equity | 20.9% | 78.3% |
| P/E ratio | 25.7 | 12.6 |
| Dividend yield | — | 2.8% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
See the full IQV vs ZTS breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open IQV's full financials → Open ZTS's full financials →Frequently asked questions
Which is bigger, IQV or ZTS?
IQVIA Holdings Inc. is larger by market capitalization — $34.4B versus $32.1B.
Which grows faster, IQV or ZTS?
Over the last five fiscal years, IQVIA Holdings Inc. grew revenue faster — 7.5%/yr versus 7.2%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.